Juan Carlos Lopez-Alvarenga
Overview
Explore the profile of Juan Carlos Lopez-Alvarenga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGowan R, Brown H, Lopez-Alvarenga J, Restrepo B
BMJ Public Health
. 2025 Feb;
2(2):e001189.
PMID: 40018550
Objective: There is a known association between type 2 diabetes (diabetes) and tuberculosis (TB), and TB clinics have become hubs for new diabetes diagnosis among active patients with TB. However,...
2.
Omana-Guzman I, Rosas-Diaz M, Martinez-Lopez Y, Perez-Navarro L, Diaz-Badillo A, Alanis A, et al.
BMC Med
. 2024 Nov;
22(1):548.
PMID: 39574069
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a prevalent hepatic condition linked to metabolic alterations. It gradually causes liver damage and...
3.
Rosas-Carrasco O, Manrique-Espinoza B, Lopez-Alvarenga J, Mena-Montes B, Omana-Guzman I
J Nutr Health Aging
. 2024 Sep;
28(11):100368.
PMID: 39307074
Objectives: Aging involves significant changes in body composition, marked by declines in muscle mass and bone mineral density alongside an increase in fat mass. Sarcopenia is characterized by low strength...
4.
Sobrino-Cossio S, Emura F, Teramoto-Matsubara O, Araya R, Parra-Blanco A, White J, et al.
Ann Gastroenterol
. 2024 Jul;
37(4):410-417.
PMID: 38974081
Background: The use of antifoaming and mucolytic agents prior to upper gastrointestinal (GI) endoscopy and a thorough systematic review are essential to optimize lesion detection. This study evaluated the effect...
5.
Lopez-Alvarenga J, Rasa C, Banu J, Mito S, Chavez A, Reyna S
Ethn Dis
. 2024 Jun;
33(1):55-60.
PMID: 38846261
Mexican Americans living in the Rio Grande Valley (RGV) have a high prevalence of type 2 diabetes (T2D). The US-Mexico border frontier has a unique blended culture of American lifestyle...
6.
Akhtar F, Ruiz J, Liu Y, Resendez R, Feliers D, Morales L, et al.
bioRxiv
. 2023 Nov;
PMID: 37961304
CC-chemokine ligand 2 (CCL2) is involved in the pathogenesis of several diseases associated with monocyte/macrophage recruitment, such as HIV-associated neurocognitive disorder (HAND), tuberculosis, and atherosclerosis. The rs1024611 (alleles:A>G; G is...
7.
Garibay-Nieto N, Pedraza-Escudero K, Omana-Guzman I, Garces-Hernandez M, Villanueva-Ortega E, Flores-Torres M, et al.
Medicina (Kaunas)
. 2023 Oct;
59(10).
PMID: 37893503
: Metabolic-dysfunction-associated steatotic liver disease or MASLD is the main cause of chronic liver diseases in children, and it is estimated to affect 35% of children living with obesity. This...
8.
Garces-Hernandez M, Pedraza-Escudero K, Garibay-Nieto N, Hernandez-Ruiz J, Prieto-Chavez J, Arriaga-Pizano L, et al.
J Cardiovasc Dev Dis
. 2022 Oct;
9(10).
PMID: 36286282
The differential contribution of monocyte subsets expressing the C-C chemokine receptor 2 (CCR2) to subclinical atherosclerosis in girls and boys is unclear. In this pilot study, we compared classical, intermediate,...
9.
Valdez Ortiz R, Escorza-Valdivia S, Benitez-Renteria S, Lopez-Alvarenga J, Perez-Navarro L
Arch Med Res
. 2022 Jul;
53(5):524-532.
PMID: 35803828
Background: Mexico has a high prevalence of chronic kidney disease (CKD) but limited information about the early stages of CKD and their clusters of poor prognosis factors (PPF) such as...
10.
Venkatesan V, Lopez-Alvarenga J, Arya R, Ramu D, Koshy T, Ravichandran U, et al.
Front Endocrinol (Lausanne)
. 2022 May;
13:847692.
PMID: 35498404
To assess the burden of type 2 diabetes (T2D) and its genetic profile in endogamous populations of India given the paucity of data, we aimed to determine the prevalence of...